Top States
Medipharm Labs Top StatesApr 2026
Top states where Medipharm Labs is active based on indexed sales coverage.
Is this your Brand? Log in to Hoodie!
Medipharm Labs
Apr 2026
Overview
MediPharm Labs offers high-quality, innovative products to consumers and patients across Canada. With our sophisticated, pharmaceutical-quality GMP-certified platform and R&D capabilities, we have created best-in-class products, with the formulations, potency, and purity to meet...
MEDIPHARM LABS faces a steep decline with YoY sales down 10.2%, slipping from rank #5 to #7 in Ontario. Yet, a recent 3-month trend shows a surprising uptick of 8.3% in sales, suggesting potential recovery within the mid-tier market.
Categories
OralConcentratesEdiblesVapesFlowerTopicals
- Top Category: Oral
- Price Tier: Mid-Market
- States Active: 3
Trend View
Market Insights SnapshotApr 2026
24-Month Trend
Average Price
$16.18
YoY Sales Trend
10.2%
2Y Sales Trend
36.6%
Oral products dominate at 46.0% of total sales but are down 18.1% YoY. Concentrates have gained traction at 31.2%, up 17.9% YoY, while Flower plummets 55.1%, the slowest category.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 46.4% | $27.12 | 18.1% |
| Concentrates | 31.5% | $14.27 | 17.9% |
| Edibles | 11.8% | $10.34 | 4.6% |
| Vapes | 7.1% | $14.2 | 41.7% |
| Flower | 1.7% | $2.66 | 55.1% |
| Topicals | 1.6% | $44.5 | 27.9% |
Trend View
Market Insights SnapshotApr 2026
24-Month Trend
Average Price
$16.18
YoY Sales Trend
10.2%
2Y Sales Trend
36.6%
Category Breakout
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 46.4% | $27.12 | 18.1% |
| Concentrates | 31.5% | $14.27 | 17.9% |
| Edibles | 11.8% | $10.34 | 4.6% |
| Vapes | 7.1% | $14.2 | 41.7% |
| Flower | 1.7% | $2.66 | 55.1% |
| Topicals | 1.6% | $44.5 | 27.9% |
State Rank Table
| State | Oral | Concentrates | Edibles | Vapes | Flower | Topicals |
|---|---|---|---|---|---|---|
| British Columbia | 5 | 7 | ⊖ | ⊖ | ⊖ | 10 |
| Alberta | 10 | 5 | 15 | ⊖ | ⊖ | 9 |
| Ontario | 9 | ⊖ | ⊖ | ⊖ | ⊖ | 13 |
MEDIPHARM LABS is primarily concentrated in Ontario (45.1%), followed by Alberta (32.5%) and British Columbia (22.4%). This geographic footprint highlights its presence across 3 key states.
| State | Oral | Concentrates | Edibles | Vapes | Flower | Topicals |
|---|---|---|---|---|---|---|
| 5 | 7 | ⊖ | ⊖ | ⊖ | 10 | |
| 10 | 5 | 15 | ⊖ | ⊖ | 9 | |
| 9 | ⊖ | ⊖ | ⊖ | ⊖ | 13 |
Market Position
Competitive LandscapeApr 2026
Competitive summary unavailable.
SKU View
Top Selling ProductsApr 2026
Top products for Apr 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1  | Flower | 2.3% |
#2  | Edibles | 6.8% |
#3 ![Thc 30 Regular Formula Oil [30ml]](/_next/image?url=https%3A%2F%2Fdata-item-images.s3.us-east-2.amazonaws.com%2Fsuccess%2Ff530589675120914387ddd5998a6688c&w=64&q=75){kind=small} | Oral | 3.4% |
#4  | Pre-Rolls | 2.2% |
#5  | Edibles | 103.6% |
#6Cbd [1000mg] | Vapes | 2.0% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Medipharm Labs using competitive landscape rank coverage, proximity, and momentum.
